Mingdu Tech Received Around $14 Million In Series A Financing

Smart Medicines manufacturing platform Mingdu Tech just received around 14 million dollars in Series A financing. This round of financing was led by Cash Capital, and followed by Collaborative Innovation Investment. The funds will be used for drug R&D,  promotion and development of the new production systems. On the other hand, the company will also use the funds to recruit new technical and sales teams.

Founded in 2017, Mingdu Tech is a company dedicated to smart manufacturing in the pharmaceutical industry. The company provides solutions for the production and development stages of medicines. It also uses data analytics to help customers to improve research and development efficiency. At present, Livzon Pharmaceutical, Wuhan Jianmin and Bikang Pharmaceutical are using Mindu Tech’s services.

Cash Capital invests in emerging industries such as information technology and healthcare and focuses on fast-growing businesses in the start-up and growth-stage in China.

Collaborative Innovation Investment is an investment company that was founded by Peking University in China.